Epclusa

'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Endpoints
Mon, 03/28/22 - 10:08 am
HHS
Bayh-Dole Act
drug pricing
Pfizer
Gilead Sciences
Xtandi
Paxlovid
Epclusa
Descovy
insulin
FDA Approves Gilead’s Epclusa for Children with Hepatitis C
BioSpace
Fri, 03/20/20 - 10:43 am
Epclusa
hepatitis C
Gilead Sciences
FDA
pediatric
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway
Fierce Pharma
Mon, 02/4/19 - 11:40 am
Gilead Sciences
hepatitis C
Epclusa
drug ads
television ads
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
CP Wire
Mon, 09/24/18 - 09:34 am
Gilead Sciences
generics
Epclusa
Harvoni
hepatitis C
Asegua Therapeutics
Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C
Mon, 09/24/18 - 09:22 am
Gilead
Epclusa
Harvoni
5 Drugs That Are Critical for Gilead Sciences' Future
Motley Fool
Thu, 02/22/18 - 09:18 am
Gilead Sciences
Biktarvy
Yescarta
selonsertib
filgotinib
Epclusa
The 1 Thing Missing From Gilead Sciences' 2018 Priority List
Motley Fool
Tue, 11/21/17 - 10:37 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Epclusa
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
Wed, 07/19/17 - 07:55 pm
AbbVie
Gilead Sciences
hepatitis C
Vosevi
Harvoni
Sovaldi
Epclusa
Viekira Pak
Gilead's HCV NDA Means Nothing
Seeking Alpha
Sun, 12/11/16 - 11:55 am
Gilead Sciences
hepatitis C
SOF/VEL/VOX
Epclusa
AbbVie
After The Deluge, Hep C Players Look For Opportunity
Seeking Alpha
Thu, 11/17/16 - 09:57 am
hepatitis C
Gilead Sciences
AbbVie
Epclusa
glecaprevir/pibrentasvir
sofosbuvir/velpatasvir
AbbVie's pan-genotypic hep C prospect shines in trials, putting the heat on rival Gilead
Fierce Pharma
Tue, 11/15/16 - 09:36 am
AbbVie
hepatitis C
Gilead Sciences
Epclusa
What’s New with Gilead Sciences?
Market Realist
Mon, 10/10/16 - 09:16 am
Gilead Sciences
GS-5745
Truvada
Odefsey
Epclusa
Gilead Sciences, Inc. HCV Script Data: Epclusa May Lighten The Blow
Bidness, ETC
Mon, 08/15/16 - 10:00 am
Gilead Sciences
hepatitis C
Epclusa
prescription data
Gilead secures European approval for new hepatitis C drug
BioPharma Dive
Mon, 07/11/16 - 11:23 am
Gilead Sciences
Europe
hepatitis C
Epclusa
3 Potential Stock-Moving Drug Events In The Second Half Of 2016
Investors.com
Fri, 07/1/16 - 10:07 am
Eli Lilly
solanezumab
Alzheimer's disease
Gilead Sciences
hepatitis C
Sovaldi
Harvoni
Epclusa
Sanofi
Regeneron
Praluent
Why Gilead's new hepatitis C drug is a game changer — price and all
Bizjournals.com
Tue, 06/28/16 - 05:37 pm
Gilead Sciences
hepatitis C
drug pricing
Epclusa